SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Wells Fargo Maintains Overweight on Bio-Rad Laboratories, Raises Price Target to $525

Wells Fargo maintains Bio-Rad Laboratories (NYSE:BIO) with a Overweight and raises the price target from $495 to $525.

Benzinga · 05/21/2020 11:20

Wells Fargo maintains Bio-Rad Laboratories (NYSE:BIO) with a Overweight and raises the price target from $495 to $525.